Home management of mild-moderate coronavirus disease-19 patients in low-resource countries: Reducing the burden on hospitals and a guide to clinical excellence

Abstract

The severe acute respiratory syndrome coronavius-2 (SARS-CoV-2) pandemic since when it was reported from Wuhan, China, in December 2019 has spread dramatically and rapidly affecting all countries and territories of the world. The morbidity and mortality rates of coronavirus disease (COVID-19) continue to climb each day with over 88 million people infected and more than 2 million deaths reported worldwide. This puts health-care systems and health-care professionals/providers (HCPs) at risk. At present, the health-care systems of the poor and low resource are unable to cope with these extremely difficult circumstances. The main objective of this article is to serves as a guideline for treating patients with mild or moderate symptoms of COVID-19 at home in over to reduce the already over burden health infrastructure, especially in developing nations. With the permission of the ethical committee of the institutions COVID-19 case management team, this article reviewed protocol-based guideline aimed at infection prevention and control to protect the health worker, the patient, his relatives, and the community and also drug treatment to help prevent the progression of the disease to severe or critical. The home treatment guideline will help poor and low-resource countries cope with the increase in number of patients with COVID-19 and ameliorate the negative effects on health-care resources for such countries that are already burden by poor or limited health system infrastructure, low workforce, and inadequate expertise to cope with the rapidity with which the virus spread.